Search

Search Constraints

You searched for: Author/Creator Mamessier, Emilie

Search Results

1. BTN3A molecules considerably improve Vγ9Vδ2T cells-based immunotherapy in acute myeloid leukemia. (2nd October 2016)

2. Circulating tumor DNA predicts efficacy of a dual AKT/p70S6K inhibitor (LY2780301) plus paclitaxel in metastatic breast cancer: plasma analysis of the TAKTIC phase IB/II study. Issue 10 (30th March 2022)

3. Dual Programmed Death Receptor‐1 and Vascular Endothelial Growth Factor Receptor‐2 Blockade Promotes Vascular Normalization and Enhances Antitumor Immune Responses in Hepatocellular Carcinoma. Issue 4 (14th October 2019)

4. Immune landscape of inflammatory breast cancer suggests vulnerability to immune checkpoint inhibitors. (1st January 2021)

5. Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature. Issue 1 (10th January 2022)

7. Loss of primary cilia promotes inflammation and carcinogenesis. (25th October 2022)

8. Low cholesterol biosynthesis favors epithelial‐to‐mesenchymal transition maintenance and influences tumor molecular subtyping and disease‐free survival in colon cancer patients. Issue 8 (30th June 2022)